Ausgabe Sonderheft 1/2003
24th Congress of the International Association for Breast Cancer Research. Advances in human breast cancer research: preclinical models
Inhalt (63 Artikel)
Estrogen receptor alpha-positive and negative mouse mammary tumors through somatic mutations of p53 in mammary carcinogenesis
S-CJ Lin, K-F Lee, AY Nikitin, KM Bushnell, SG Hilsenbeck, RD Cardiff, A Li, K-W Kang, SA Frank, W-H Lee, EY-HP Lee
Integrin-mediated signal transduction in transgenic mouse models of human breast cancer
DE White, S Blaess, U Mueller, S Dedhar, RD Cardiff, R St Arnaud, WJ Muller
Reversibility and progression in conditional transgenic mouse models of breast cancer
LA Chodosh, RB Boxer, SE Moody, BA Keister, CJ Sarkisian, JW Jang, GK Belka, CM Blakely, CP Portocarero, CJ Sterner, KL Notarfrancesco, EA Kauh
Positron emission tomography and X-ray computed tomography: tools for mouse phenotyping?
SR Cherry
Genetically modified cancer models: the value of luciferase-tagged tumors and in vivo luciferase-based reporter assays in oncology drug discovery
W Yang, C Kowal, E Sorensen, P Lassota
Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
RH Schwall, P Hollingshead, S Erickson, J Winer, M Williams, D Dugger
Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression
LM Wakefield, Y Yang, O Dukhanina, B Tang, M Mamura, JL Letterio, J Green, GT Merlino, MR Anver
Development of a transgenic mouse line for the evaluation of the androgen receptor activity in vivo
R Attar, C Cullinan, C-P Ho, M Swerdel, J Dell, RB Rowley, DJ Bol, J Ostrowski, K Mookhtiar, M Gottardis, R Weinmann
Pregnancy levels of estrogen prevents breast cancer
S Nandi, RC Guzman, G Thordarson, L Rajkumar
The molecular biology of mammary intraepithelial neoplasia outgrowths
L Namba, SY Liu, ET McGoldrick, LJT Young, AD Borowsky, RD Cardiff, JP Gregg
The comparative genetics and genomics of cancer: of mice and men
G Hodgson, J Hager, K Chin, CA Lapuk, S Volik, C Collins, A Balmain, F Waldman, D Hanahan, J Gray
Proof-of-concept in vivo evaluation of targeted therapeutics: lessons from immunoliposomes
CC Benz
The mouse in preclinical trials: transgenic, carcinogen-induced, or xenograph models – which to use?
P Brown
Transgenic models are predictive: the herceptin and flavopiridol experience
E Schmidt
Genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat
JD Shull, BS Schaffer, LM Bartsch, LK Buckles, KA Gould, M Tochacek, B Xie, CM Lachel, KL Pennington, TE Strecker, KK Hansen
Transforming growth factor β's role in mammary gland development and carcinogenesis
MH Barcellos-Hoff
Function of LEF1 in early mammary development
K Kratochwil, S Tontsch, R Grosschedl
Expression profiling of breast cancer, influence of tumor genotype and patient genotype
A-L Borresen-Dale
Using genomic similarities and differences to interpret mouse models of human development and cancer
L Stubbs, C Elso, G Loots, A Hamilton, I Ovcharenko
A hybrid functional/anatomical imaging system for high-throughput planar projection mouse imaging
JM Boone, K Yang
Imaging mouse models of breast cancer with positron emission tomography
S Cherry, C Abbey, S Borowsky, J Gregg, R Cardiff
Imaging angiogenesis in early stages of breast cancer using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor
S Mandl, FG Blankenberg, Y-A Cao, C O'Connell-Rodwell, C Mari, TI Gaynutdinov, J-L Vanderheyden, MV Backer, JM Backer, C Contag
Ultrasound imaging of tumor perfusion
K Ferrara, P Dayton, R Pollard, A Broumas, E Wisner
Mammary intraepithelial neoplasia outgrowths (MINO): MINO and human ductal carcinoma in situ
AD Borowsky
Premalignancy in the human breast: how is it defined, is morphology good enough?
BA Gusterson
Regulation of human mammary stem cells
RB Clarke, E Anderson, A Howell, H Okano, CS Potten
Characterization, isolation and cultivation of distinctive human breast cell populations
R Villadsen, T Gudjonsson, A Fridriksdottir, M Wissing, L Rønnov-Jessen, MJ Bissell, OW Petersen
Stem cells in normal breast development and breast cancer
MS Wicha, G Dontu, M Al-Hajj, MF Clarke
Functional characterization of mammary stem cells in development and breast cancer
JM Rosen, BE Welm, SB Tepera, F Behbod, SL Grimm, T Venezia, MA Goodell, TA Graubert, Z Werb, Y Li, HE Varmus
Prevention of breast tumor angiogenesis and metastasis by cytostatic molecules in relevant mouse models
M Crépin, M DiBenedetto, R Bagheri-Yarmand, A Starzec, R Vassy, G Perret
Mouse models for pretesting of immunotherapeutic strategies for cancer patients
JM Burchell, DW Miles, A Mungul, T Plunkett, R Sewell, G Picco, I Correa, J Taylor-Papadimitriou
Target discovery in the postgenomic era
L Friedman, L Johnson, H Francis-Lang, M Costa, D Baly, G Duyk, G Plowman
Rational engineering of Fc/Fc receptor interactions to improve antibody potency
S Doberstein, G Lazar, R Hayes
From gene expression patterns to antibody diagnostics
DT Ross, BZ Ring, S Chang, Y Wang, C McDaniel, S Defoe, R Beck, R Seitz
Clinical applications of Affymetrix Genechip arrays for RNA and DNA analysis
I Russell
Combined hormonal therapy for advanced breast cancer in postmenopausal patients
P Langecker, W Lang, D Blanchett, P Bailey, C Scribner, P Goss